Companies / United Kingdom
GSK Acquires Reliant Pharmaceuticals
November 2007 | Industry NewsUK-based drugmaker GlaxoSmithKline has paid US$1.7bn to acquire privately held US firm Reliant Pharmaceuticals. BMI believes that the move is an attempt by GSK to boost it pipeline for cardiovascular drugs, which is considered relatively weak compared to rivals such as Pfizer.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
